Clinical Trial NCT06100900
Trial
BioCryst – BCX10013-105 (NCT06100900)
Clinical trial ID
NCT06100900
Drug name
BCX10013
Company:
BioCryst
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
1
Current status
Recruiting
Start
10/2023
Substance
---
Research question
Evaluation of safety, tolerability, pharmacokinetics, pharmacodynamics and therapeutic potential of BCX10013
Delivery method of drug
Oral
Frequency
Daily for 4 weeks, then maybe escalation
Clinical trial locations
South Africa